2JVY | pdb_00002jvy

Solution Structure of the EDA-ID-related C417F mutant of human NEMO zinc finger


Experimental Data Snapshot

  • Method:&nbspSOLUTION NMR
  • Conformers Calculated:&nbsp200&nbsp
  • Conformers Submitted:&nbsp10&nbsp
  • Selection Criteria:&nbspstructures with the lowest energy&nbsp

wwPDB Validation&nbsp3D Report&nbspFull Report

Validation slider image for 2JVY

This is version 1.4 of the entry. See complete&nbsphistory.&nbsp

Literature

Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.

Cordier, F.,&nbspVinolo, E.,&nbspVeron, M.,&nbspDelepierre, M.,&nbspAgou, F.

(2008) J Mol Biol&nbsp377: 1419-1432

  • DOI:&nbsphttps://doi.org/10.1016/j.jmb.2008.01.048
  • Primary Citation Related Structures:&nbsp
    2JVX, 2JVY

  • PubMed Abstract:&nbsp

    The regulatory NEMO (NF-kappaB essential modulator) protein has a crucial role in the canonical NF-kappaB signaling pathway notably involved in immune and inflammatory responses, apoptosis and oncogenesis. The regulatory domain is located in the C-terminal half of NEMO and contains a classical CCHC-type zinc finger (ZF). We have investigated the structural and functional effects of a cysteine to phenylalanine point mutation (C417F) in the ZF motif, identified in patients with anhidrotic ectodermal dysplasia with immunodeficiency. The solution structures of the wild type and mutant ZF were determined by NMR. Remarkably, the mutant adopts a global betabetaalpha fold similar to that of the wild type and retains thermodynamic stability, i.e., the ability to bind zinc with a native-like affinity, although the last zinc-chelating residue is missing. However, the mutation induces enhanced dynamics in the motif and leads to an important loss of stability. A detailed analysis of the wild type solution structure and experimental evidences led to the identification of two possible protein-binding surfaces that are largely destabilized in the mutant. This is sufficient to alter NEMO function, since functional complementation assays using NEMO-deficient pre-B and T lymphocytes show that full-length C417F pathogenic NEMO leads to a partial to strong defect in LPS, IL-1beta and TNF-alpha-induced NF-kappaB activation, respectively, as compared to wild type NEMO. Altogether, these results shed light onto the role of NEMO ZF as a protein-binding motif and show that a precise structural integrity of the ZF should be preserved to lead to a functional protein-recognition motif triggering full NF-kappaB activation.


  • Organizational Affiliation:&nbsp
    • Institut Pasteur, Unité de RMN des Biomolécules; CNRS, URA 2185, F-75015 Paris, France. [email protected]

Macromolecule Content&nbsp

  • Total Structure Weight: 3.35 kDa&nbsp
  • Atom Count: 227&nbsp
  • Modeled Residue Count: 28&nbsp
  • Deposited Residue Count: 28&nbsp
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
NF-kappa-B essential modulator28N/AMutation(s): 1&nbsp
UniProt & NIH Common Fund Data Resources
Find proteins for&nbspQ9Y6K9&nbsp(Homo sapiens)
Explore&nbspQ9Y6K9&nbsp
Go to UniProtKB: &nbspQ9Y6K9
PHAROS: &nbspQ9Y6K9
GTEx: &nbspENSG00000269335&nbsp
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9Y6K9
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands&nbsp1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ZN

Query on ZN



Download:Ideal Coordinates CCD File
B [auth A]ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method:&nbspSOLUTION NMR
  • Conformers Calculated:&nbsp200&nbsp
  • Conformers Submitted:&nbsp10&nbsp
  • Selection Criteria:&nbspstructures with the lowest energy&nbsp

Structure Validation

View&nbspFull Validation Report



Entry History&nbsp

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2008-03-18
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2020-02-19
    Changes: Database references, Derived calculations, Other
  • Version 1.3: 2021-10-20
    Changes: Database references, Derived calculations
  • Version 1.4: 2024-05-08
    Changes: Data collection, Database references